Menu

Tyvaso IPF Data In NEJM Reframes United Therapeutics Growth Potential

Article |

Wander.Builder2... 2mo ago
Tyvaso IPF Data In NEJM Reframes United Therapeutics Growth Potential

United Therapeutics now has fresh late stage data on Tyvaso sitting in a top tier journal, which represents a clear milestone for any drug developer. With the...

Comments (0)

Newest

No comments yet.